Search results
Author(s):
Vikram Sharma
,
Arpit Sothwal
,
Jai Parekh
,
et al
Added:
1 year ago
Author(s):
Sabu Thomas
,
Andrew J Boyle
,
Gary S Francis
Added:
3 years ago
Acute decompensated heart failure (ADHF) is a syndrome defined by worsening fatigue, dyspnea, or edema that results from deteriorating heart function and usually leads to hospital admission or unscheduled medical intervention.1 Among patients over 65 years of age it remains the leading cause of hospital admission (>1 million admissions per year in the US alone), has an exceptionally high rate…
View more
Author(s):
Enoch Akowuah
Added:
1 year ago
ACC.23/WCC—DrEnoch Akowuah (James Cook University Hospital, UK) joins us to share the findings of the UK Mini-Mitral trial (National Institute of Health Research).
This study is a multicentre, expertise-based randomised controlled trial that aimed to compare the safety and effectiveness of a minimally-invasive thoracotomy compared to conventional sternotomy in treating patients with degenerative…
View more
Author(s):
Jacob Green
,
Vasilis Babaliaros
,
Peter Block
Added:
3 years ago
Mitral regurgitation (MR) is the most prevalent form of valvular heart disease. Its major causes are primary mitral leaflet abnormalities (valve prolapse, healed endocarditis, or rheumatic disease), primary myocardial disease (functional MR), and ischemic disease. Even with severe MR, affected individuals may remain asymptomatic for long periods of time.1 The early, compensated state of MR is…
View more
Author(s):
Alexandra Gonçalves
,
Carla Sousa
,
José Alberto de Agustín
,
et al
Added:
3 years ago
Valvular disease is the most prevalent structural heart disease among adults and its burden is growing along with the increase in life expectancy.1 Mitral regurgitation (MR) is the second most frequent valvular disease, after aortic stenosis. Its natural history is very variable and highly dependent on the presence of symptoms. However, even in asymptomatic patients, the prognosis of severe MR is…
View more
Author(s):
Payam Pournazari
,
Su Min Chang
,
Stephen H Little
,
et al
Added:
1 year ago
Author(s):
Mohamed Adnan Alkhouli
Added:
1 year ago
TCT 22 - Dr Mohamed Alkhouli (Mayo Clinic, Jacksonville, FL, US) joins us to outline the findings from the TVT Registry, a benchmarking tool created to monitor the real-world outcomes of transcatheter mitral valve repair. In this prospective observational study, 4000 patients with mitral valve regurgitation were observed after implantation with the mitraclip device to evaluate the safety and…
View more
Author(s):
Trevor J Simard
,
Mackram F Eleid
Added:
2 years ago
Author(s):
Howard C Herrmann
Added:
3 years ago
Mitral regurgitation (MR) is most often caused by degenerative disease of the leaflets or develops functionally as a consequence of left ventricular disease (see Figure 1). Patients with severe MR have dyspnea on exertion, fatigue, and, when associated with left ventricular dysfunction or pulmonary hypertension, reduced survival.1 Therefore, surgery to repair or replace the mitral valve is…
View more
Author(s):
Kendra J Grubb
,
Isida Byku
Added:
1 year ago
In this USC Discussion, Special Focus Editor Dr Kendra Grubb (Emory Structural Heart and Valve Center, US) is joined by Dr Isida Byku (Emory School of Medicine, Druid Hills, GA, US) to discuss her recent review article,"Valve-in-valve Transcatheter Aortic Valve Replacement for Failed Surgical Valves and Adjunctive Therapies".
Discussion Points:
22s: How many patients are affected by failed TAVR…
View more